Gastric Space Occupying Devices Market Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The Gastric Space Occupying Devices Market is projected to grow from USD 219.2 million in 2024 to an estimated USD 299.99 million by 2032, with a compound annual growth rate (CAGR) of 4% from 2024 to 2032.The global gastric space-occupying devices market has emerged as a significant segment within the broader weight management and obesity treatment sector. These devices, designed to occupy space within the stomach to induce a feeling of satiety, have gained attention as non-invasive alternatives to traditional weight-loss surgeries. With the rising prevalence of obesity worldwide and increasing awareness about minimally invasive solutions, the market for gastric space-occupying devices is poised for substantial growth.

Browse the full report at https://www.credenceresearch.com/report/gastric-space-occupying-devices-market

Overview of Gastric Space-Occupying Devices

Gastric space-occupying devices, such as intragastric balloons, are temporary devices inserted into the stomach to limit food intake by reducing available gastric volume. Typically, these devices are made of biocompatible materials like silicone and are filled with saline or gas. They are generally placed using endoscopic procedures and are removed after a specified duration, usually 6-12 months.

Key products in this market include single and dual intragastric balloons, adjustable balloons, and liquid-filled or air-filled devices. Notable companies such as Apollo Endosurgery, ReShape Lifesciences, and Spatz FGIA are prominent players innovating in this domain.

Market Drivers

1. Increasing Prevalence of Obesity
   According to the World Health Organization (WHO), global obesity rates have tripled since 1975. Sedentary lifestyles, unhealthy diets, and genetic predispositions contribute to this trend. Gastric space-occupying devices offer a less invasive and cost-effective solution compared to bariatric surgery, making them appealing to a wider demographic.

2. Rising Demand for Minimally Invasive Treatments
   Patients are increasingly opting for minimally invasive procedures that offer shorter recovery times and reduced risks. Gastric space-occupying devices meet these criteria, providing effective weight-loss solutions without the need for permanent surgical alterations.

3. Technological Advancements
   Innovations such as adjustable balloons, longer durability, and self-swallowable capsules are expanding the usability and patient compliance of these devices. For example, newer devices like the Elipse Balloon eliminate the need for endoscopic placement and removal, simplifying the procedure.

4. Growing Awareness and Acceptance
   Increased awareness of obesity-related health risks, such as cardiovascular diseases and diabetes, has led to higher acceptance of weight-loss interventions. Marketing campaigns and endorsements from healthcare professionals further promote the adoption of these devices.

Challenges and Restraints

While the gastric space-occupying devices market shows promise, it faces several challenges:

1. High Costs
   Despite being less expensive than bariatric surgery, these devices are still costly for many patients. Limited insurance coverage for obesity treatments further restricts market growth.

2. Adverse Effects and Complications
   Potential side effects, such as nausea, vomiting, abdominal pain, and balloon deflation, may deter patients. Proper training for healthcare professionals and better device designs are essential to address these issues.

3. Regulatory Hurdles
   Stringent regulatory requirements can delay product approvals and market entry. Manufacturers must invest significant time and resources in meeting safety and efficacy standards.

Future Outlook

The gastric space-occupying devices market is set to grow at a significant compound annual growth rate (CAGR) over the next decade. Key trends shaping the future include:

• Emergence of Non-Endoscopic Devices: Innovations like self-swallowable balloons are expected to simplify procedures and expand patient adoption.
• Integration of Digital Health Solutions: Wearable devices and mobile apps for monitoring weight loss and adherence to treatment will enhance patient outcomes.
• Focus on Emerging Markets: Manufacturers are targeting regions with rising obesity rates and untapped potential, such as Asia-Pacific and Africa.

 

Key Player Analysis:

• Allurion Technologies, Inc.
• Apollo Endosurgery, Inc.
• Endalis
• Helioscopie
• Lexel Medical
• MEDSIL
• Obalon Therapeutics, Inc.
• ReShape Medical, Inc.
• Scientific Intake

Segmentation:

By Product:

• Gastric Balloons
• Oral Palatal Space Occupying Devices

By End-User:

• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centers

By Region:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/gastric-space-occupying-devices-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]